This inventor holds 2 USPTO granted patents. Top assignees: Phoenix Pharmacologics, Inc., Phoenix Pharmacologies, Inc.. Active years: 2003-2005.
Company Filing History:
Years Active: 2003-2005
Title: The Innovations of Charles Mark Ensor
Introduction
Charles Mark Ensor is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic agents. With a total of 2 patents, Ensor's work focuses on addressing critical health issues related to uric acid levels and cancer treatment.
Latest Patents
Ensor's latest patents include a PEG-modified uricase, which is directed towards treating illnesses characterized by increased circulating uric acid levels, such as hyperuricemia and tumor lysis syndrome. This innovative approach utilizes polyethylene glycol to enhance the efficacy of uricase. Another significant invention is a mutated form of arginine deiminase, which is genetically modified for more efficient manufacturing and processing. This invention also encompasses recombinant DNA molecules and vectors, along with therapeutic and pharmaceutical compositions aimed at treating cancer and other disease states.
Career Highlights
Throughout his career, Ensor has worked with various companies, including Phoenix Pharmacologics, Inc. and Phoenix Pharmacologies, Inc. His expertise in biotechnology has allowed him to contribute to advancements in medical treatments and therapies.
Collaborations
Some of his notable coworkers include Mike A Clark and Frederick Wayne Holtsberg. Their collaborative efforts have furthered the development of innovative solutions in the field of biotechnology.
Conclusion
Charles Mark Ensor's contributions to biotechnology through his patents and collaborations highlight his commitment to improving health outcomes. His work continues to influence the development of effective treatments for critical health conditions.